ALV:XETRAllianz SE Analysis
Data as of 2026-09-04 - not real-time
$125.05
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
Autoliv, Inc. is priced at $125.05 and its moving averages line up in bullish order, the shorter sitting above the longer. Over a rolling month the price has gained 8.5%. Momentum indicators put RSI at 57.1 (neutral) with MACD reading bearish. Price has been bracketed by support at $118.52 and resistance at $125.86.
Valuation screens as fair, on a P/E of 14.3 with no clean sector comparison available. The average analyst target implies 7.7% above today's level. Revenue is growing at 3.3% on a 5.8% profit margin.
Risk scores 4 out of 10, which is moderate for this asset class. With 30-day volatility of 24.0%, a beta of 1.10 and a maximum drawdown of 22.6%, position sizing matters here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
Across every horizon the signals point the same way: buy, at a conviction of 5 out of 10.
Valuation screens as fair, on a P/E of 14.3 with no clean sector comparison available. The average analyst target implies 7.7% above today's level. Revenue is growing at 3.3% on a 5.8% profit margin.
Risk scores 4 out of 10, which is moderate for this asset class. With 30-day volatility of 24.0%, a beta of 1.10 and a maximum drawdown of 22.6%, position sizing matters here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
Across every horizon the signals point the same way: buy, at a conviction of 5 out of 10.
Top Market Events
Shares of automotive safety systems provider Autoliv NYSE:ALV fell 3.Autoliv Inc ALV reports a robust quarter with record sales and strategic partnerships, despite facing geopolitical and...Autoliv, Inc. NYSE: ALV SSE: ALIV.sdb , the worldwide leader in automotive safety systems, today announced that its...
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 6/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 119.10
- MACD momentum is negative
Medium Term
1–3 yearsPositive
Model confidence: 5/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 119.10
- Analyst targets imply +7.7% versus the current price
Long Term
> 3 yearsPositive
Model confidence: 5/10
Key Factors
- Analyst targets imply +7.7% versus the current price
- P/E ratio of 14.3
- Return on equity of 25.9%
Key Metrics & Analysis
Financial Health
Revenue Growth3.30%
Profit Margin5.80%
P/E Ratio14.3
ROE25.86%
ROA8.29%
Debt/Equity87.53
P/B Ratio3.7
Op. Cash Flow$1.2B
Free Cash Flow$742.1M
Technical Analysis
TrendBullish
RSI57.1
Support$118.52
Resistance$125.86
MA 20$122.20
MA 50$120.94
MA 200$119.10
MACDBearish
VolumeIncreasing
Fear & Greed Index96.09
Valuation
Fair Value$122.67
Target Price$134.71
Upside/Downside7.72%
GradeFair
TypeBlend
Risk Assessment
Beta1.10
Volatility23.99%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.